Robots in the Care Wing: How Elder-Care Robotics Is Becoming Reimbursable Infrastructure by 2027

Quick answer: Elder-care robotics is transitioning from academic pilots into structured deployment, with unusually strong analyst convergence around USD 3.3–4.05 billion for 2026, growing at a consistent 12.4–16.5% CAGR toward USD 6.5–10.3 billion by 2030–2035. No dedicated CMS reimbursement code exists yet for companion or humanoid robots, but Medicare's 2026 fee schedule quietly lowered the bar for adjacent remote-monitoring codes — building payment rails robotics-enabled care will likely plug into as government pilots in China, South Korea, and the UK generate the evidence base regulators need before assigning permanent billing codes.
Executive Overview

Elder-care robotics is transitioning from isolated academic pilots into a structured deployment pipeline backed by national government programs, procurement marketplaces, and — increasingly — reimbursement-adjacent billing infrastructure, even though no dedicated CMS reimbursement code for companion or humanoid robots exists as of 2026. The eldercare assistive robots market shows unusually strong analyst convergence around USD 3.3–4.05 billion for 2026, growing at a consistent 12.4%–16.5% CAGR toward USD 6.5–10.3 billion by 2030–2035, while parallel Medicare policy changes to remote patient monitoring (RPM) and chronic care management (CCM) codes are quietly building the payment rails robotics-enabled care will eventually plug into.

1. Market Size: Rare Convergence Across Research Firms

Unlike most loneliness-economy sub-segments, where estimates diverge by 10x or more, eldercare assistive robot sizing shows tight clustering across six independent research firms — an unusual and analytically meaningful convergence signaling genuine market maturity rather than definitional confusion.

Roots Analysis values the market at USD 3.56 billion in 2026, reaching USD 10.27 billion by 2035 at a 12.5% CAGR. Research and Markets projects USD 4.05 billion in 2026 growing to USD 7.37 billion by 2030 at a 16.1% CAGR, narrowing from a 16.5% CAGR observed in the prior 2025–2026 growth step. Persistence Market Research estimates USD 3.7 billion in 2026 rising to USD 9.4 billion by 2033 at 14.2% CAGR, explicitly citing "structural demand for continuous, non-institutional elder support" as the primary driver. Grand View Research corroborates this closely with USD 3.9 billion in 2026 reaching USD 9.8 billion by 2033, also at 14.2% CAGR.

TechSci Research offers a slightly lower base of USD 2.89 billion for 2024 growing to USD 6.47 billion by 2030 at 14.35% CAGR, while Global Industry Analysts projects USD 3.1 billion in 2024 reaching USD 7.7 billion by 2030 at 16.1% CAGR, further segmenting physically assistive robots (17.8% CAGR) as outgrowing socially assistive robots (12.8% CAGR).

A related but distinct sub-segment — elderly-care and companion robots emphasizing social/emotional rather than physical assistance — is valued far lower at USD 563 million for 2026, projected to reach USD 5.24 billion by 2036 at a steep 25.0% CAGR, a figure Future Market Insights explicitly attributes to public social-support and dementia-care spending rather than consumer electronics purchasing cycles. National growth rates within this segment vary by welfare-delivery model: South Korea leads at 27.0% CAGR, followed by the United States (25.0%), Japan (24.0%), and the European Union (23.0%) — reflecting how centralized welfare systems adopt robotics faster than fragmented national purchasing frameworks.

2. Government-Led Pilot Programs Signal Institutionalization

China launched the most aggressive state-directed program in June 2025, requiring participating companies and research institutes to deploy at least 200 robots to 200 households for trial periods of six months or longer, addressing "the full life-cycle needs of elder adults, including daily care, rehabilitation, psychological support and emotional companionship." Major Chinese robotics firms — Unitree Robotics, UBTech, Fourier, and AgiBot — are all participating, and results expected in 2026 will likely shape global policy given the scale of the resulting dataset. Hangzhou has gone further, opening an Embodied Intelligence Pilot Base offering data access, computing power, and scenario-validation services to accelerate the transition of humanoid elder-care robots from lab to deployment, with a target of 200 benchmark application scenarios opened in 2026 alone.

South Korea's Seoul Welfare Foundation launched a parallel but more targeted 2026 Care Service Digital Transformation Support pilot, deploying AI and robotics across six nursing facilities selected from 40 applicants, each receiving roughly 7 million won (about USD 4,300) in project funding plus technical consulting focused on physically taxing, high-injury-risk care tasks such as patient transfers, fall monitoring, and pressure-ulcer prevention.

In the UK, Realbotix — via a NASDAQ-listed parent, Onconetix — is piloting humanoid companion robots in Northeast England care homes through Bloom Procurement Services, a public-sector procurement specialist, explicitly designed to supplement rather than replace human caregivers while evaluating resident engagement, cognitive health indicators, and loneliness outcomes. Analysis of the UK policy landscape notes that neither the Department of Health and Social Care nor the NHS currently has a formal policy on humanoid care robots, even as NEO-brand humanoids are expected to ship to US homes in late 2026 and to Europe in 2027.

3. Deployed Products and Commercial Status

A cross-national snapshot of active humanoid and companion robots in elder care shows a market still spanning early commercial deployment and government-subsidized rollout. South Korea's Hyodol, a ChatGPT-powered companion doll offering medication reminders and emergency alerts, has more than 12,000 units deployed under government subsidy and is planning a US market launch in 2026. China's Yang Yang companion humanoid is deployed in Chengdu care homes under government pilot, providing morning wake-ups, weather updates, and activity reminders.

Andromeda Robotics' Abi, a social humanoid already operating in Australian assisted-living facilities, has opened a waitlist for US assisted-living deployment after generating strong resident receptivity in early trials. RobotGym's Xiaoru, a home-care humanoid capable of functioning as mobility support while assisting with food delivery and cleaning, is entering pilot programs across Chinese eldercare institutions with mass production planned for 2026.

Intuition Robotics' ElliQ remains the most clinically documented product in market, having been deployed across 15 U.S. government aging-services agencies, with New York State's Office for the Aging reporting a 95% reduction in loneliness among a 107-person sample using ElliQ for at least 30 days. Intuition Robotics, founded in 2016 and headquartered across Europe, Middle East, and North Africa regions, remains active with venture-series funding of undisclosed amount per Crunchbase records.

4. Reimbursement Infrastructure: The Missing Link to Scale

No CMS-recognized CPT code currently exists specifically for companion or humanoid elder-care robots, and coding guidance for adjacent robotic-assistance codes such as HCPCS S2900 (surgical robotic assistance) is explicitly informational only, carrying no attached reimbursement.

However, CMS's 2026 Medicare Physician Fee Schedule Final Rule, released November 5, 2025 and effective January 1, 2026, substantially lowered the bar for remote monitoring reimbursement in ways directly relevant to robot-enabled elder care: a new CPT code 99445 now allows Medicare payment for device data collected across just 2–15 days per month (versus the prior 16-day minimum), paid at the same rate as the existing 16+ day code 99454, which itself rose from USD 43.02 to USD 52.11. A new treatment-management code 99470 now permits billing for just 10–19 minutes of monthly monitoring engagement at USD 26.05, roughly half the value of the existing 20-minute code 99457, which itself increased from USD 47.87 to USD 51.77.

Chronic Care Management (CCM) codes, which cover ongoing care coordination that robot-enabled monitoring could feasibly support, also rose materially for 2026: the base 20-minute non-complex CCM code 99490 increased from USD 60.49 to USD 66.13, while complex CCM code 99487 (first 60 minutes) rose from USD 131.65 to USD 144.29.

As of January 2026, only 26 CPT codes exist for clinical AI solutions overall, of which just three have received permanent Category I codes (FFR-CT cardiovascular risk analysis, and diabetic retinopathy imaging tools); every other AI-enabled billing code remains Category III — temporary codes used to collect utilization data but without guaranteed payment. This Category III status is the critical bottleneck: it means elder-care robotics companies today can bill physicians for adjacent RPM/CCM services their platforms support, but cannot yet bill Medicare directly for the robot or its companionship function itself — explaining why current deployment is dominated by government grants, procurement marketplaces, and pilot subsidies rather than standard health-insurance billing.

5. The Path to 2027: What "Reimbursable Infrastructure" Requires

Three converging trends suggest elder-care robotics could achieve reimbursable status within the near term.

First, CMS's proposed changes to RPM and clinical AI payment models, opened for public comment in mid-2026 with implementation timing still to be determined, explicitly target how AI-enabled clinical decision support and remote monitoring tools are billed — a policy vehicle robotics companies could plausibly be folded into if they can demonstrate clinical monitoring functionality equivalent to existing RPM devices.

Second, China's national pilot program, results of which are expected in 2026, will generate the largest structured dataset globally on elder-care robot effectiveness — a dataset likely to influence reimbursement policy debates in other markets by providing the evidentiary base regulators require before assigning permanent billing codes.

Third, policy analysts studying the UK's NHS gap explicitly recommend that "local authorities and integrated care systems should be resourced for commissioner-led pilots of 20–50 units," using NHS Kent's PARO pilot as the template for how a modest, structured social-care pilot can eventually inform national commissioning policy — the same evidentiary pathway CMS has historically required before assigning Category I status to a new technology.

6. Strategic Recommendations

For robotics companies: Build products that map explicitly onto existing RPM/CCM billable activities (fall monitoring, medication adherence, care coordination) now, rather than waiting for a dedicated "companion robot" CPT code — this lets providers bill for adjacent services your platform enables today, funding deployment ahead of formal reimbursement.

For investors: The rare cross-firm market-size convergence (six firms within a $3.3–4.05B band) is itself a signal of reduced category-definition risk relative to other loneliness-economy segments covered in this report series — underwrite with more confidence in the base case here than in categories showing 10x+ analyst disagreement.

For health systems and policymakers: The UK's "no formal policy" gap is a genuine first-mover opportunity; following the NHS Kent PARO pilot template (20–50 unit commissioner-led pilots) provides a lower-risk path to the evidentiary base CMS and equivalent bodies require before assigning permanent billing codes.

For elder-care robotics operators globally: China's 2026 pilot results will likely become the reference dataset for reimbursement debates worldwide, given its scale (200 robots, 200 households, 6+ months); operators outside China should track and cite this data proactively rather than waiting for domestic equivalents.

7. Outlook Through 2027 and Beyond

Expect China's 2026 pilot results to become the pivotal evidentiary reference point shaping reimbursement policy conversations in the US, UK, and South Korea through 2027. CMS's public-comment process on RPM and clinical AI payment models is the most likely near-term vehicle for elder-care robotics to gain adjacent billing recognition, though a dedicated Category I CPT code specifically for companion/humanoid robots remains unlikely before 2028 given the current 3-of-26 permanent-code base rate for AI-enabled billing overall. The defining strategic question through 2027 is whether reimbursement follows the RPM/CCM adjacent-billing path outlined in this report, or whether a dedicated companion-robot code emerges directly — the former is significantly more probable given current regulatory precedent.

Methodology and Key Caveats

Figures in this report are drawn from six independent market-research firms (Roots Analysis, Research and Markets, Persistence Market Research, Grand View Research, TechSci Research, Global Industry Analysts), government policy sources (CMS 2026 Physician Fee Schedule Final Rule, Chinese government pilot program documentation, Seoul Welfare Foundation announcements), and industry/policy analysis (Bipartisan Policy Center, Medicaid Monitor), current as of September 2026. The eldercare assistive robots market shows unusually tight convergence across sources (a rare pattern in loneliness-economy market sizing), which this report treats as a meaningful signal of category maturity rather than coincidence. CMS reimbursement figures are drawn directly from the published 2026 fee schedule and represent verified, authoritative rates rather than estimates.

Sources

Market Data: Roots Analysis; Research and Markets; Persistence Market Research; Grand View Research; TechSci Research; Global Industry Analysts (MarketResearch.com); Future Market Insights

Government Pilots & Policy: Bastille Post (Hangzhou); RoboZaps; Korea Times (Seoul Welfare Foundation); Investing.com (Realbotix); LinkedIn (NHS policy analysis)

Deployed Products: ABC7 News (Andromeda Robotics' Abi); LinkedIn (RobotGym Xiaoru); Crunchbase (Intuition Robotics profile)

Reimbursement & Regulatory: CMS 2026 Physician Fee Schedule Final Rule; ESRUN Health; Health Recovery Solutions; California Medical Association (Coding Corner); Bipartisan Policy Center; Medicaid Monitor

Inquiries

General Inquiries
contact@lonelinesseconomy.com

Research & Data Inquiries

research@lonelinesseconomy.com
Partnerships & Commercial Inquiries
Partnerships@lonelinesseconomy.com